Discovery and development of a new oxazolidinone with reduced toxicity for the treatment of tuberculosis

Journal:

Nature Medicine

Published:

2026-01-13

DOI:

10.1038/s41591-025-04164-x

Affiliations:

12

Authors:

32

Go to article

Institutions	Authors	Share
Merck & Co, United States of America (USA)	12.000000 12.000000	0.38
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA)	7.000000	0.22
Gates Foundation, United States of America (USA)	5.000000	0.16
Colorado State University, United States of America (USA)	5.000000	0.16
Hackensack Meridian Health, United States of America (USA)	3.000000	0.09

Interested in Medical Microbiology?